Barclays’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$329K Buy
72,842
+26,084
+56% +$118K ﹤0.01% 3264
2025
Q1
$207K Sell
46,758
-29,104
-38% -$129K ﹤0.01% 3302
2024
Q4
$594K Buy
75,862
+6,640
+10% +$52K ﹤0.01% 2952
2024
Q3
$910K Buy
69,222
+56,244
+433% +$739K ﹤0.01% 2674
2024
Q2
$156K Sell
12,978
-12,760
-50% -$153K ﹤0.01% 3171
2024
Q1
$418K Sell
25,738
-24,699
-49% -$401K ﹤0.01% 2937
2023
Q4
$344K Buy
50,437
+44,135
+700% +$301K ﹤0.01% 3226
2023
Q3
$34K Sell
6,302
-1,015
-14% -$5.48K ﹤0.01% 3748
2023
Q2
$49K Sell
7,317
-40,092
-85% -$268K ﹤0.01% 3684
2023
Q1
$237K Buy
47,409
+37,550
+381% +$188K ﹤0.01% 3052
2022
Q4
$48K Sell
9,859
-54,586
-85% -$266K ﹤0.01% 3791
2022
Q3
$929K Buy
64,445
+61,634
+2,193% +$888K ﹤0.01% 2193
2022
Q2
$43K Sell
2,811
-2,984
-51% -$45.6K ﹤0.01% 3784
2022
Q1
$68K Sell
5,795
-54,183
-90% -$636K ﹤0.01% 3853
2021
Q4
$972K Buy
59,978
+42,509
+243% +$689K ﹤0.01% 2224
2021
Q3
$498K Buy
17,469
+10,615
+155% +$303K ﹤0.01% 2611
2021
Q2
$232K Sell
6,854
-27,147
-80% -$919K ﹤0.01% 2827
2021
Q1
$1.03M Buy
34,001
+21,857
+180% +$661K ﹤0.01% 2284
2020
Q4
$602K Sell
12,144
-36,411
-75% -$1.8M ﹤0.01% 2244
2020
Q3
$1.87M Sell
48,555
-3,449
-7% -$132K ﹤0.01% 1547
2020
Q2
$2.25M Buy
52,004
+41,223
+382% +$1.78M ﹤0.01% 1400
2020
Q1
$281K Sell
10,781
-17,281
-62% -$450K ﹤0.01% 2395
2019
Q4
$878K Buy
28,062
+15,361
+121% +$481K ﹤0.01% 2378
2019
Q3
$331K Sell
12,701
-418
-3% -$10.9K ﹤0.01% 2829
2019
Q2
$300K Sell
13,119
-3,133
-19% -$71.6K ﹤0.01% 2985
2019
Q1
$426K Buy
16,252
+5,913
+57% +$155K ﹤0.01% 2700
2018
Q4
$210K Buy
+10,339
New +$210K ﹤0.01% 2699